title: Urine drug testing for pain management.
abstract: An epidemic of prescription drug abuse in the United States has increased the burden on clinical toxicology testing laboratories. Urine drug testing provides objective evidence for compliance and aberrant drug behavior in patients on chronic (non-cancer) pain management. This article describes the testing menu, drug testing assays including tandem mass spectrometry and their limitations, interpretation of opiate results and clinical considerations.
authors.affiliation: Department of Pathology and Laboratory Medicine, Tufts Medical Center, 800 Washington Street, Box 115, Boston MA 02115, USA. bjmagnani@tuftsmedicalcenter.org
authors.forename: Barbarajean
authors.initials: B
authors.lastname: Magnani
authors.forename: Tai
authors.initials: T
authors.lastname: Kwong
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use* / Q000652:urine*; D006801:Humans; D007118:Immunoassay; D055118:Medication Adherence; D059408:Pain Management / Q000379:methods*; D010349:Patient Compliance; D015813:Substance Abuse Detection / Q000379:methods*; D053719:Tandem Mass Spectrometry; D016482:Urinalysis / Q000379:methods*
chemical_list: D000701:Analgesics, Opioid